Molnatris 200mg Capsule

Welcome to the information page for Molnatris 200mg Capsule, brought to you by Mylan Pharmaceuticals Pvt Ltd - A Viatris Company. This product contains the active ingredient Molnupiravir (200mg) and is indicated for Treatment of Mild to moderate Coronavirus disease (COVID-19). Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

MRP: ₹ 1970
Packing: 40.0 capsules in 1 bottle
Salt Combination: Molnupiravir (200mg)
Brand: Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Uses: Treatment of Mild to moderate Coronavirus disease (COVID-19)

Description

Molnatris 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults
It prevents the virus from multiplying, thereby reducing viral load and disease severity
The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021
Molnatris 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms
The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases
It is not indicated in patients who require immediate hospitalization due to COVID-19
This drug has also been approved by the U.S
Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.Molnatris 200mg Capsule should be taken orally for no longer than 5 consecutive days
It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better
The medicine may cause dizziness, headache, diarrhea, and nausea in some patients
If one experiences any such side effects, discuss them with the doctor
They may help with the treatment or suggest ways to prevent them.
Before taking Molnatris 200mg Capsule, let the doctor know if you have any pre-existing medical conditions
To make sure it is safe for you, inform your doctor about all the other medications you are taking
The use of Molnatris 200mg Capsule is not recommended in pregnant women
Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Cautions

Liver:	SAFE IF PRESCRIBED: Molnatris 200mg Capsule is safe to use in patients with liver disease. No dose adjustment of Molnatris 200mg Capsule is recommended.
Kidney:	SAFE IF PRESCRIBED: Molnatris 200mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Molnatris 200mg Capsule is recommended.
Driving:	CONSULT YOUR DOCTOR: It is not known whether Molnatris 200mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Breast feeding:	UNSAFE: Molnatris 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnency:	CONSULT YOUR DOCTOR: Molnatris 200mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Molnatris 200mg Capsule. Please consult your doctor.
Drug Action:	Antiviral (Non-HIV) drugs
Therapeutic class:	ANTI INFECTIVES
Habit Forming:	No
Chemical Class:	Cytosine Nucleotides

Uses of Molnatris 200mg Capsule

In Treatment of Mild to moderate Coronavirus disease (COVID-19) Molnatris 200mg Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration
This medicine may help you recover from the infection if diagnosed early before hospitalization
If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.